Nu-Med Plus Depreciation & Amortization Growth & History (NUMD)

Nu-Med Plus's depreciation and amortization was $0 for fiscal 2025.

View full Nu-Med Plus company overview

Nu-Med Plus annual depreciation and amortization history

Nu-Med Plus annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$0$0
20242024-12-31$0$0
20232023-12-31$0−$2,267
20222022-12-31$2,267−$7,098−75.79%
20212021-12-31$9,365−$2,429−20.60%
20202020-12-31$11,794−$1,572−11.76%
20192019-12-31$13,366−$1,377−9.34%
20182018-12-31$14,743$2,200+17.54%
20172017-12-31$12,543$5,395+75.48%
20162016-12-31$7,148−$1−0.01%
20152015-12-31$7,149$185+2.66%
20142014-12-31$6,964$3,769+117.97%
20132013-12-31$3,195$1,378+75.84%
20122012-12-31$1,817

Nu-Med Plus depreciation and amortization trends

Over the last five fiscal years, Nu-Med Plus's depreciation and amortization decreased from $11,794 to $0, a change of −$11,794. The latest reported quarter, Q2 2026, shows $0.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nu-Med Plus source filings ↗

Community posts

It’s quiet here.

No posts about NUMD yet. Start the conversation.

Write the first post